Doxycycline-inducible gain- and loss of function studies in mice provide evidence that de novo visceral adipocyte differentiation in the face of caloric excess protects against unhealthy WAT remodeling in obesity, and is associated with preservation of the insulin-sensitizing hormone adiponectin and systemic insulin sensitivity. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.